On-treatment factors predict recompensation in entecavir-treated hepatitis B patients with decompensated cirrhosis

被引：0

作者：

Deng, You ^{[1
]}

Zheng, Huanwei ^{[2
]}

Xiang Huiling ^{[3
]}

Nan, Yuemin ^{[4
]}

Hu, Jinhua ^{[5
]}

Meng, Qinghua ^{[6
]}

Zhao, Hong ^{[1
]}

Wang, Qi ^{[1
]}

Fang, Jilian ^{[7
]}

Xu, Jie ^{[8
]}

Wang, Xiaoming ^{[9
]}

Pan, Calvin Q. ^{[10
]}

You, Hong ^{[9
]}

Xu, Xiaoyuan ^{[11
]}

Xie, Wen ^{[1
]}

Jia, Ji-Dong ^{[9
]}

机构：

[1] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China

[2] Shijiazhuang Fifth Hosp, Shijiazhuang, Hebei, Peoples R China

[3] Tianjin Third Cent Hosp, Tianjin, Peoples R China

[4] Hebei Med Univ, Hosp 3, Shijiazhuang, Hebei, Peoples R China

[5] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China

[6] Capital Med Univ, Beijing You Hosp, Beijing, Peoples R China

[7] Peking Univ Peoples Hosp, Beijing, Peoples R China

[8] Peking Univ Third Hosp, Beijing, Peoples R China

[9] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China

[10] NYU Sch Med, NYU Langone Med Ctr, Dept Med, Div Gastroenterol & Hepatol, New York, NY USA

[11] Peking Univ First Hosp, Beijing, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

WED-332

引用

页码：S243 / S243

页数：1

共 50 条

[21] THROMBOSPONDIN-1 AS A PREDICTIVE BIOMARKER FOR RECOMPENSATION IN PATIENTS WITH CHRONIC HEPATITIS B AND DECOMPENSATED CIRRHOSIS
Deng, You
Zhao, Hong
Wang, Qi
Li, Jiashuo
Chen, Wenya
Li, Mengqi
Xie, Wen
HEPATOLOGY, 2024, 80 : S1695 - S1696
[22] Predictors of Baveno VII criteria for recompensation in patients with hepatitis B-related decompensated cirrhosis
Hui, Vicki Wing-Ki
Yip, Terry Cheuk-Fung
Wong, Vincent Wai-Sun
Chan, Henry L. Y.
Wong, Grace Lai-Hung
JOURNAL OF HEPATOLOGY, 2023, 78 : S1131 - S1131
[23] Impact of switching to tenofovir alafenamide fumarate in patients with entecavir-treated chronic hepatitis B
Kumada, Takashi
Toyoda, Hidenori
Yasuda, Satoshi
Ito, Takanori
Tanaka, Junko
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E898 - E904
[24] Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg
Wang, Chia-Chi
Tseng, Kuo-Chih
Hsieh, Tsai-Yuan
Tseng, Tai-Chung
Lin, Hans Hsienhong
Kao, Jia-Horng
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (09): : 1286 - 1294
[25] COST-EFFECTIVENESS OF ENTECAVIR VERSUS ADEFOVIR FOR THE TREATMENT OF CHRONIC HEPATITIS B IN PATIENTS WITH DECOMPENSATED CIRRHOSIS
Tsai, Naoky
Jeffers, Lennox
Cragin, Lael
Sorensen, Sonja
Su, Wayne
Rosenblatt, Lisa C.
Tang, Hong
Hebden, Tony
Juday, Timothy
HEPATOLOGY, 2011, 54 : 596A - 596A
[26] Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis
Shim, Ju Hyun
Lee, Han Chu
Kim, Kang Mo
Lim, Young-Suk
Chung, Young-Hwa
Lee, Yung Sang
Suh, Dong Jin
JOURNAL OF HEPATOLOGY, 2010, 52 (02) : 176 - 182
[27] Entecavir can significantly improve the prognosis of patients with first decompensated hepatitis B cirrhosis
Ding, Rui
Xie, Wen
Jia, Jidong
Wang, Qi
JOURNAL OF HEPATOLOGY, 2024, 80 : S228 - S229
[28] RECOMPENSATION IS ASSOCIATED WITH IMPROVED OUTCOMES IN PATIENTS WITH DECOMPENSATED CIRRHOSIS FROM AUTOIMMUNE HEPATITIS
Wong, Yu Jun
Lytvyak, Ellina
Singh, Noreen
Moctezuma-Velazquez, Carlos
Abraldes, Juan
Mason, Andrew
Montano-Loza, Aldo
HEPATOLOGY, 2024, 80 : S1850 - S1851
[29] SERUM N-GLYCANS AS PREDICTIVE BIOMARKERS FOR RECOMPENSATION IN PATIENTS WITH CHRONIC HEPATITIS B AND DECOMPENSATED CIRRHOSIS
Deng, You
Wang, Qi
Zhao, Hong
Wu, Qian
Chen, Cuiying
Chen, Wenya
Li, Jiashuo
Li, Mengqi
Xie, Wen
HEPATOLOGY, 2024, 80 : S1693 - S1693
[30] Lactic acidosis during Entecavir treatment in decompensated hepatitis B virus-related cirrhosis
Marzano, Alfredo
Marengo, Andrea
Marietti, Milena
Rizzetto, Mario
DIGESTIVE AND LIVER DISEASE, 2011, 43 (12) : 1027 - 1028

← 1 2 3 4 5 →